Hidrotic ectodermal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:189OMIM:129500Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hidrotic ectodermal dysplasia, also known as Clouston syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias — conditions that affect structures derived from the embryonic ectoderm. It is caused by mutations in the GJB6 gene, which encodes connexin 30, a gap junction protein important for cell-to-cell communication in the skin and its appendages. Unlike other forms of ectodermal dysplasia, hidrotic ectodermal dysplasia notably preserves sweat gland function (hence the term 'hidrotic,' meaning sweating is intact), while primarily affecting the hair, nails, and skin. The hallmark clinical features include severe nail dystrophy (thickened, slow-growing, discolored, or absent nails), sparse to absent scalp hair (hypotrichosis or alopecia that may be progressive), and sparse or absent body hair including eyebrows and eyelashes. The nails are often the most consistently affected feature and may be present from birth or early childhood. Palmoplantar hyperkeratosis — thickening of the skin on the palms and soles — is another common finding. Teeth and sweat glands are typically normal, which distinguishes this condition from hypohidrotic forms of ectodermal dysplasia. Some affected individuals may also develop hyperpigmentation of the skin, particularly over the joints. There is currently no cure for hidrotic ectodermal dysplasia. Treatment is symptomatic and supportive, focusing on management of nail abnormalities, skin care for hyperkeratotic areas, and cosmetic solutions such as wigs for hair loss. Dermatologic follow-up is recommended. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern. The condition was originally described in a large French-Canadian kindred, and notable clusters have been reported in this population, though cases occur worldwide across various ethnic groups.

Also known as:

Clinical phenotype terms— hover any for plain English:

Small nailHP:0001792Sparse axillary hairHP:0002215Absent axillary hairHP:0002221Sparse pubic hairHP:0002225Absent pubic hairHP:0002555Generalized hypotrichosisHP:0004528
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hidrotic ectodermal dysplasia.

View clinical trials →

No actively recruiting trials found for Hidrotic ectodermal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hidrotic ectodermal dysplasia community →

No specialists are currently listed for Hidrotic ectodermal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hidrotic ectodermal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hidrotic ectodermal dysplasiaForum →

No community posts yet. Be the first to share your experience with Hidrotic ectodermal dysplasia.

Start the conversation →

Latest news about Hidrotic ectodermal dysplasia

No recent news articles for Hidrotic ectodermal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hidrotic ectodermal dysplasia

What is Hidrotic ectodermal dysplasia?

Hidrotic ectodermal dysplasia, also known as Clouston syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias — conditions that affect structures derived from the embryonic ectoderm. It is caused by mutations in the GJB6 gene, which encodes connexin 30, a gap junction protein important for cell-to-cell communication in the skin and its appendages. Unlike other forms of ectodermal dysplasia, hidrotic ectodermal dysplasia notably preserves sweat gland function (hence the term 'hidrotic,' meaning sweating is intact), while primarily affecting the hair, nails, and skin

How is Hidrotic ectodermal dysplasia inherited?

Hidrotic ectodermal dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hidrotic ectodermal dysplasia typically begin?

Typical onset of Hidrotic ectodermal dysplasia is childhood. Age of onset can vary across affected individuals.